Aspen Releases Positive Results

South African drugmaker Aspen has released positive financial results for 2009, highlighting its key growth drivers as the GlaxoSmithKline (GSK) interdependent transactions, which have given Aspen the rights to distribute selected GSK products in Sub-Saharan Africa, and its shift in focus from public to private sector sales in its home market.

To read the full article, please choose one of the following options: